Read Time:7 Second
Lupin Limited has informed the Exchange regarding a press release dated August 12, 2025, titled “Lupin Announces Licensing Deal for Ranibizumab Biosimilar”. |SUBJECT: Press Release
Lupin Limited has informed the Exchange regarding a press release dated August 12, 2025, titled “Lupin Announces Licensing Deal for Ranibizumab Biosimilar”. |SUBJECT: Press Release